Bewersdorf JP, Shallis RM, Sharon E, Park S, et al. A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents. Ann Hematol 2023 Dec 1. doi: 10.1007/s00277-023-05552.
PMID: 38036712